Transferrin aldifitox

N/A

Report date: 2024/04/10 16:08:20

Base Information

Drug NameTransferrin aldifitox
Drug Alias NameTransMIDTransferrin-CRM-107Project KSB-311RTransMID-107RTransMID-107N +[16] 
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionProtein biosynthesis inhibitorsAnti-Transferrin receptor protein 1
TargetsTransferrin receptor protein 1
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe HealthcareNational Institute of Health, IslamabadXenova Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedison PharmaNational Institutes Of HealthNycomed Pharmaceutical +[9] 
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A